Published in N Engl J Med on January 08, 1976
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48
Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry (1989) 3.32
The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther (2000) 3.07
Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry (2000) 2.70
Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand (2001) 2.42
False neurotransmitters and hepatic failure. Lancet (1971) 2.34
Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry (1989) 2.07
Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr Scand (2007) 1.87
The catatonic syndrome. Lancet (1976) 1.82
Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand (2008) 1.78
Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Arch Gen Psychiatry (1978) 1.72
Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry (2000) 1.71
Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int J Dev Neurosci (2000) 1.71
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry (2000) 1.66
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry (1997) 1.61
Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry (2000) 1.61
Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry (1998) 1.60
The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry (1983) 1.60
Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophr Res (2006) 1.57
Gender differences in chronic major and double depression. J Affect Disord (2000) 1.53
Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand (2003) 1.52
Lithium salts: 1970-1975. Ann Intern Med (1975) 1.48
Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry (1994) 1.45
A review of 32 cases of tardive dystonia. Am J Psychiatry (1991) 1.45
The effect of drugs on the release of norepinephrine-H from central nervous system tissued by electrical stimulation in vitro. J Pharmacol Exp Ther (1967) 1.44
Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry (1980) 1.43
Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry (1992) 1.43
Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry (1996) 1.42
Research reports on treatments for bipolar disorder: preliminary assessment of methodological quality. Acta Psychiatr Scand (2005) 1.41
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40
Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry (1992) 1.40
Interactions of serotonin reuptake inhibitors with tricyclic antidepressants. Arch Gen Psychiatry (1994) 1.39
Conversions from clozapine to other antipsychotic drugs. Arch Gen Psychiatry (1995) 1.39
A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry (1993) 1.39
Severe daytime somnolence in patients treated with an MAOI. Am J Psychiatry (1988) 1.38
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry (2000) 1.28
Lost human capital from early-onset chronic depression. Am J Psychiatry (2000) 1.25
Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression. Arch Gen Psychiatry (1993) 1.24
Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry (1989) 1.23
Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry (2001) 1.22
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry (1975) 1.20
Pharmacologically induced behavioural supersensitivity to apomorphine. Nat New Biol (1973) 1.19
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry (1997) 1.18
Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia. Am J Psychiatry (1988) 1.16
Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry (1998) 1.14
Effects of lithium and of pH on synaptosomal metabolism of noradrenaline. Nature (1970) 1.14
Lecithin can suppress tardive dyskinesia. N Engl J Med (1978) 1.14
Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry (1998) 1.14
Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study. Dev Neurosci (1999) 1.13
Pharmacologic treatment of depression during pregnancy. JAMA (1999) 1.12
Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry (1998) 1.12
Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand (2009) 1.11
The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry (1985) 1.11
Risks and implications of interrupting maintenance psychotropic drug therapy. Psychother Psychosom (1995) 1.11
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand (2006) 1.10
Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology (1973) 1.10
A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. J Am Acad Child Adolesc Psychiatry (1989) 1.10
Antidepressant-related akathisia. J Clin Psychopharmacol (1987) 1.09
Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Neurosci Lett (1998) 1.09
Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry (1999) 1.09
Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology (1991) 1.09
A sensitive and specific enzymatic isotopic assay for tissue histamine. J Pharmacol Exp Ther (1966) 1.08
"Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry (1980) 1.08
Pathogenesis and therapy of hepatic coma. Prog Liver Dis (1976) 1.07
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry (1998) 1.05
Factors associated with noncompliance with psychiatric outpatient visits. Psychiatr Serv (2001) 1.03
Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res Dev Brain Res (1998) 1.03
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry (1991) 1.02
Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry (2001) 1.02
Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors. Neuroscience (1998) 1.02
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry (1996) 1.01
S-(+)-aporphines are not selective for human D3 dopamine receptors. Cell Mol Neurobiol (1994) 1.01
Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes (Lond) (2006) 1.01
Motor effects of serotonin in the central nervous system. Life Sci (1980) 1.00
Regulation of catecholamine synthesis in the rat brain in vitro by cyclic AMP. Nature (1974) 1.00
Metabolism of norepinephrine in the central nervous system. Pharmacol Rev (1966) 1.00
Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology (1974) 0.99
Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv Rev Psychiatry (1997) 0.99
Psychotic reactions during amitriptyline therapy. Can Psychiatr Assoc J (1968) 0.97
Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry (1992) 0.97
Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry (1996) 0.97
Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry (1979) 0.97
Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol (1994) 0.97
Fluoxetine and side effects. Arch Gen Psychiatry (1990) 0.96
Tritiated norepinephrine: release from brain slices by electrical stimulation. Science (1966) 0.96
Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull (1993) 0.96
Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry (1977) 0.96
Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf (1996) 0.95
Effects of L-dopa on norepinephrine metabolism in the brain. Proc Natl Acad Sci U S A (1971) 0.95
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. Neuropsychopharmacology (1993) 0.95
Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci (1997) 0.95
A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl) (1979) 0.95
(+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res (1991) 0.94
Tryptophan depletion and depressive vulnerability. Biol Psychiatry (1999) 0.93
The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry (1977) 0.93
Clozapine in severe mood disorders. J Clin Psychiatry (1995) 0.93
Formation of catechol compounds from phenylalanine and tyrosine with isolated nerve endings. Nat New Biol (1972) 0.92